GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » INVO Bioscience Inc (NAS:INVO) » Definitions » E10

INVO Bioscience (INVO Bioscience) E10 : $-16.71 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is INVO Bioscience E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

INVO Bioscience's adjusted earnings per share data for the three months ended in Mar. 2024 was $-0.420. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-16.71 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was 6.40% per year. During the past 5 years, the average E10 Growth Rate was 4.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of INVO Bioscience was 10.70% per year. The lowest was 4.60% per year. And the median was 6.40% per year.

As of today (2024-06-12), INVO Bioscience's current stock price is $0.748999. INVO Bioscience's E10 for the quarter that ended in Mar. 2024 was $-16.71. INVO Bioscience's Shiller PE Ratio of today is .


INVO Bioscience E10 Historical Data

The historical data trend for INVO Bioscience's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

INVO Bioscience E10 Chart

INVO Bioscience Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -18.88 -20.19 -13.53 -16.39 -16.57

INVO Bioscience Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.54 -16.77 -16.64 -16.57 -16.71

Competitive Comparison of INVO Bioscience's E10

For the Medical Devices subindustry, INVO Bioscience's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


INVO Bioscience's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, INVO Bioscience's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where INVO Bioscience's Shiller PE Ratio falls into.



INVO Bioscience E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, INVO Bioscience's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.42/131.7762*131.7762
=-0.420

Current CPI (Mar. 2024) = 131.7762.

INVO Bioscience Quarterly Data

per share eps CPI Adj_EPS
201212 -0.010 96.871 -0.014
201312 -0.010 98.326 -0.013
201412 -0.020 99.070 -0.027
201503 -1.114 99.621 -1.474
201506 -34.261 100.684 -44.841
201509 -0.575 100.392 -0.755
201512 -1.140 99.792 -1.505
201603 -0.846 100.470 -1.110
201606 -6.626 101.688 -8.587
201609 -0.960 101.861 -1.242
201612 -1.258 101.863 -1.627
201703 -0.974 102.862 -1.248
201706 -0.620 103.349 -0.791
201709 -0.672 104.136 -0.850
201712 -0.907 104.011 -1.149
201803 -0.643 105.290 -0.805
201806 -8.095 106.317 -10.033
201809 -1.280 106.507 -1.584
201812 -3.200 105.998 -3.978
201903 -1.898 107.251 -2.332
201906 -0.994 108.070 -1.212
201909 -2.922 108.329 -3.554
201912 -3.100 108.420 -3.768
202003 -5.859 108.902 -7.090
202006 -5.358 108.767 -6.491
202009 -7.153 109.815 -8.583
202012 -7.901 109.897 -9.474
202103 -5.000 111.754 -5.896
202106 -3.400 114.631 -3.909
202109 -4.800 115.734 -5.465
202112 0.600 117.630 0.672
202203 -4.600 121.301 -4.997
202206 -4.620 125.017 -4.870
202209 -4.190 125.227 -4.409
202212 -4.550 125.222 -4.788
202303 -4.100 127.348 -4.243
202306 -3.060 128.729 -3.132
202309 -0.700 129.860 -0.710
202312 -0.800 129.419 -0.815
202403 -0.420 131.776 -0.420

Add all the adjusted EPS together and divide 10 will get our e10.


INVO Bioscience  (NAS:INVO) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


INVO Bioscience E10 Related Terms

Thank you for viewing the detailed overview of INVO Bioscience's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


INVO Bioscience (INVO Bioscience) Business Description

Traded in Other Exchanges
N/A
Address
5582 Broadcast Court, Sarasota, FL, USA, 34240
INVO Bioscience Inc operates as a medical device company focused on the Assisted Reproductive Technology (ART) marketplace that is creating simplified, lower-cost treatments for patients diagnosed with infertility. The company has developed the INVOcell device and procedure, the first Intravaginal Culture (IVC) system granted FDA clearance in the United States used for the incubation of eggs and sperm during fertilization and early embryo development. The company sells its products to physicians directly; and IVF centers, medical practices, and physicians through distributors.
Executives
Trent D Davis director 811 SW NAITO PARKWAY, SUITE 200, PORTLAND OR 97204
Matthew K Szot director 802 NORTH DOUTY STREET, HANFORD CA 93230
Steve Shum director 9025 SW HILLMAN COURT, SUITE 3126, WILSONVILLE OR 97070
Andrea Goren officer: Chief Financial Officer 110 EAST 59TH STREET, SUITE 1901, NEW YORK NY 10022
Barbara Ryan director 22 CAVRAY ROAD, NORWALK CT 06855
Michael Jos. Campbell director 61 SOUTH HILLS DRIVE, BEDFORD NH 03110
Rebecca Messina director 5582 BROADCAST COURT, SARASOTA FL 34240
Jeffrey Segal director INVO BIOSCIENCE, INC., 5582 BROADCAST COURT, SARASOTA FL 34240
Awm Investment Company, Inc. 10 percent owner 527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022
Kevin Doody director, officer: Medical Director 1109 SOMERSET BLVD, COLLEYVILLE TX 76034
Debra Robbins Hoopes officer: Acting CFO and PFO 1 MORTON DR., SUITE 200, CHARLOTTESVILLE VA 22903
Claude Ranoux 10 percent owner 8 CHESTNUT STREET, WINCHESTER MA 01890
Kathleen T Karloff director, officer: CEO/Chairman 109 BEACON STREET UNIT 5, BOSTON MA 02116
Bowdring Robert Joseph Jr officer: Chief Financial Officer 92 GOULD STREET, WAKEFIELD MA 01880